Diagnosis and management of ductal carcinoma in situ (DCIS)

Virnig BA, Shamliyan T, Tuttle TM, Kane RL, and Wilt TJ
Record ID 32010001602
English
Authors' recommendations: Incidence of DCIS continued to increase with no evidence of overdiagnosis or effective preventive strategies. There is a need to better identify problematic lesions from mammography that are most likely to contain some invasive breast cancer. Most prognostic factors for invasive breast cancer are also prognostic factors for DCIS. The role of MRI and SLNB should be investigated as tools to improve pre-surgical decisonmaking and staging. Breast conserving surgery with adjuvant radiotherapy can benefit all women, though the absolute impact may be small for some women. Ongoing trials will shed light on the optimal clinical strategy for treating DCIS.
Details
Project Status: Completed
URL for project: http://www.ahrq.gov/downloads/pub/evidence/pdf/dcis/dcis.pdf
Year Published: 2009
URL for published report: http://www.ahrq.gov/clinic/tp/dcistp.htm
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Disease Management
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating
Contact
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: martin.erlichman@ahrq.hhs.gov
Contact Email: martin.erlichman@ahrq.hhs.gov
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.